The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 07, 2026

Filed:

Jun. 02, 2022
Applicants:

Ardan Pharma S.a.s., Buenos Aires, AR;

Universidad DE LA República Oriental Del Uruguay, Montevideo, UY;

Institut Pasteur DE Montevideo, Montevideo, UY;

Inventors:

Marcelo Rafael Hill Mongabure, Canelones, UY;

Mercedes Segovia, Canelones, UY;

Helena Pardo Minetti, Montevideo, UY;

Álvaro Mombrú, Montevideo, UY;

Sabina Victoria, Tübingen, DE;

Analia Castro, Montevideo, UY;

Maria Inés Varela Vega, Sunchales Santa Fe, AR;

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61P 35/00 (2006.01); A61K 9/51 (2006.01); A61K 31/138 (2006.01); A61K 31/166 (2006.01); A61K 31/167 (2006.01); A61K 31/352 (2006.01); C07D 211/84 (2006.01);
U.S. Cl.
CPC ...
A61K 31/352 (2013.01); A61K 9/5161 (2013.01); A61K 31/138 (2013.01); A61K 31/166 (2013.01); A61K 31/167 (2013.01); A61P 35/00 (2018.01);
Abstract

This invention is related to an anti-tumoral composition for the treatment of neoplastic pathologies of malignant kind, and for the treatment of eg7 thymic lymphoma. Said composition comprises a TMEM176A/B inhibitor formulated in nanoparticles. This invention is also related to a method of treating neoplastic pathologies of malignant kind. Said method comprises the steps of administering to a subject a TMEM176A/B inhibitor formulated in nanoparticles.


Find Patent Forward Citations

Loading…